Back to search

Spain· ES:82517

EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO SANDOZ 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

A medicinal product containing efavirenz + emtricitabina + tenofovir, registered in Spain by Sandoz Farmaceutica S.A..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedEFAVIRENZ/EMTRICITABINA/TENOFOVIR DIS…ATC—REGISTER NO.ES:82517PACKS LISTED0CHECKEDJune 3, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
efavirenz + emtricitabina + tenofovir
Manufacturer
Sandoz Farmaceutica S.A.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
June 3, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ab2d6daf-a3c2-47eb-b16e-fe1fac4f99e3
GET /v1/drugs/ab2d6daf-a3c2-47eb-b16e-fe1fac4f99e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Uso Hospitalario",
  "estado": "{\"aut\":1507500000000,\"rev\":1731423004000}",
  "nregistro": "82517",
  "substance": "efavirenz + emtricitabina + tenofovir"
}

See everything about efavirenz + emtricitabina + tenofovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.